Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Return on Sales (2020 - 2025)

Rapid Micro Biosystems' Return on Sales history spans 6 years, with the latest figure at 1.47% for Q3 2025.

  • For Q3 2025, Return on Sales rose 2.0% year-over-year to 1.47%; the TTM value through Sep 2025 reached 1.45%, up 40.0%, while the annual FY2024 figure was 1.67%, 66.0% up from the prior year.
  • Return on Sales for Q3 2025 was 1.47% at Rapid Micro Biosystems, up from 1.63% in the prior quarter.
  • Across five years, Return on Sales topped out at 1.18% in Q4 2024 and bottomed at 4.42% in Q1 2021.
  • The 5-year median for Return on Sales is 2.37% (2024), against an average of 2.53%.
  • The largest annual shift saw Return on Sales plummeted -201bps in 2021 before it soared 200bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 2.8% in 2021, then tumbled by -34bps to 3.76% in 2022, then surged by 53bps to 1.76% in 2023, then soared by 33bps to 1.18% in 2024, then dropped by -25bps to 1.47% in 2025.
  • Per Business Quant, the three most recent readings for RPID's Return on Sales are 1.47% (Q3 2025), 1.63% (Q2 2025), and 1.56% (Q1 2025).